Apr 12, 2021

Ovarian Cancer Patients Face Increased Risk of Mental Illness

Siqi Hu, PhD, is a member of the Hashibe Lab at Huntsman Cancer Institute. Hu presented results at the 2021 virtual American Association for Cancer Research Annual Meeting that women diagnosed with ovarian cancer were more than three times more likely to be diagnosed with mental illness such as anxiety, depression, and adjustment disorder than the general public.

Apr 12, 2021

St. Peter’s Health Announces Affiliation with Huntsman Cancer Institute

St. Peter's Health announced the decision to affiliate with Huntsman Cancer Institute at the University of Utah and bring a higher level of cancer care to the Helena community. The affiliation with HCI enables patients undergoing cancer and hematology care at St. Peter's Health in Helena, Montana to access a broader variety of treatment options along with top cancer experts at HCI.

Apr 08, 2021

Huntsman Cancer Institute Research Shows Melanoma Incidence and Mortality Higher in Utah Compared to Rest of U.S.

Utah had more melanoma deaths than any other state from 1975 to 2013, says a letter published today by HCI researchers in the New England Journal of Medicine. In contrast to the rest of the United States, melanoma mortality in Utah increased by 0.8% per year over that period. The researchers say this data emphasizes the need to stay vigilant about preventing melanoma.

Mar 29, 2021

Huntsman Cancer Institute Appoints Neeraj Agarwal, MD, as Senior Director of Clinical Research Innovation

Huntsman Cancer Institute announced the appointment of physician-scientist Neeraj Agarwal, MD, as senior director of clinical research innovation. Agarwal will serve on the senior leadership of the Comprehensive Cancer Center at HCI, oversee critical components of HCI’s clinical research infrastructure, and will lead efforts to accelerate the process of bringing new, innovative clinical trial offerings to patients.

Mar 23, 2021

New Guidance for Clinical Trial Participation by Cancer Patients Receiving a COVID-19 Vaccination

An international group of cancer clinical research experts reported new recommendations that receiving a COVID-19 vaccination should not preclude a cancer patient from participating on a clinical trial. Huntsman Cancer Institute physician-scientist and professor of internal medicine at the University of Utah, Neeraj Agarwal, MD, was part of this newly formed group who reviewed the data and provided recommendations to patients, doctors, research centers, and the pharmaceutical research industry on this critical, emerging issue.

Mar 03, 2021

Utah Researchers Illuminate Potential Precursors of Blood Cancers

Utah researchers report significant new insights into the development of blood cancers. Comparing DNA data in people with and without blood disorders, the researchers discovered genetic mutations in about 2% of the presumably healthy participants that were identical to those frequently observed in the cancer patients. These findings provide new clues about mutations that may initiate cancer development and those that may help cancer progress.

Mar 02, 2021

Huntsman Cancer Institute Urges all Adults to Take Action and Schedule Health and Cancer Screenings

Huntsman Cancer Institute experts are urging people to make sure they are up to date on their cancer screenings. This message follows national trends indicating far fewer cancers diagnosed in recent months as compared to prior years. Doctors are alarmed, as there is no evidence to suggest fewer cases of cancers; rather, it is believed that cancer diagnoses are down as many individuals or organizations canceled or postponed health appointments, including cancer screenings, during the COVID-19 pandemic.

Feb 05, 2021

Sachin Apte Joins Huntsman Cancer Institute as Chief Clinical Officer

Huntsman Cancer Institute and University of Utah Health welcome Sachin Apte, MD, MS, MBA. Apte was recruited from Moffitt Cancer Center and will serve as chief clinical officer of HCI and physician-in-chief of the cancer hospital. Selected following an extensive national search, Apte begins his appointment on February 8, 2021.